The metabolic syndrome is not associated with homocysteinemia: The Persian Gulf Healthy Heart Study

Journal of Endocrinological Investigation

Volumn 32, Issue 5, 2009, Pages 406-410

  Nabipour, I ^a   Ebrahimi, A ^a   Jafari, S M ^a   Vahdat, K ^a   Assadi, M ^a   Movahed, A ^a   Moradhaseli, F ^a   Obeidi, N ^a   Sanjdideh, Z ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C reactive protein; Homocysteine; Insulin resistance; Ischemic heart disease; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOCYSTEINE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; SCORING SYSTEM;

EID: 70350339094     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346476     Document Type: Article

References (25)

1. Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999, 131: 363-375 (Pubitemid 29424631)
2. Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes Care 2001, 24: 1403-1410
3. Bjorck J, Hellgren M, Rastam L, Lindblad ULF. Associations between serum insulin and homocysteine in a Swedish population- a potential link between the metabolic syndrome and hyperhomocysteinemia: The Skaraborg project. Metabolism 2006, 55: 1007-1013
4. Fonseca V, Dicker-Brown A, Ranganathan S, et al. Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 2000, 49: 736-741 (Pubitemid 30354580)
5. Oron-Herman M, Rosenthal T, Sela BA. Hyperhomocysteinemia as a component of syndrome X. Metabolism 2003, 52: 1491-1495
6. Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. J Mol Endocrinol 2001, 27: 85-91. (Pubitemid 32771460)
7. Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation. J Mol Endocrinol 2005, 34: 119-126 (Pubitemid 40305554)
8. Tanrikulu-Kilic F, Bekpinar S, Unlucerci Y, Orhan Y. Insulin resistance is not related to plasma homocysteine concentration in healthy premenopausal women. Physiol Res 2006, 55: 285-290 (Pubitemid 43911047)
9. Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 2001, 86: 719-723
10. Giltay EJ, Hoogveen EK, Elbers JMH, Gooren UG, Asscheman H, Stehouwer CDA. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy non-obese subjects. Atherosclerosis 1998, 139: 197-198 (Pubitemid 28341883)
11. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndromes: an epidemiologic perspective. Epidemiol Rev 1998, 20: 157-172
12. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004, 27: 2444-2449 (Pubitemid 39281399)
13. Liao Y, Kwon S, Shaughnessy S, et al. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 2004, 27: 978-983 (Pubitemid 38420225)
14. Garcin JM, Cremades S, Garcia-Hejl C, et al. Is hyperhomocysteinemia an additional risk factor of the metabolic syndrome? Metab Syndr Relat Disord 2006, 4: 185-195
15. Gillum R. Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American Men: The Third National Health and Nutrition Examination Survey. Nutrition J 2003, 2: 6. (Pubitemid 38813932)
16. Rhee EJ, Hwang ST, Lee WY, et al. Relationship between metabolic syndrome categorized by newly recommended by international diabetes federation criteria with plasma homocysteine concentration. Endocrine J 2007, 54: 995-1002.
17. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285: 2486-2497
18. Prineas RJ, Crowe RS, Blackburn H. The Minnesota Code manual of electrocardiographic findings. Bristol: John Wright, 1982.
19. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006, 97 (Suppl): 3A-11A.
20. Ridker PM, Wilson WF, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004, 109: 2818-2825
21. Liao D, Yang X, Wang H. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease. Clin Chem Lab Med 2007, 45: 1652-1659 (Pubitemid 350232983)
22. Liao D, Tan H, Hui R, et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance. Cir Res 2006, 99: 565-566 (Pubitemid 44401451)
23. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determination of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001, 73: 613-621 (Pubitemid 32176514)
24. Battelle Memorial Institute. Evaluation of the behavioral risk factor surveillance system (BRFSS) as a source of national estimates for selected health risk behaviors: Final Report. Baltimore, Md: Battelle Memorial Institute, 1999.
25. Serdula M, Coates R, Byers T, et al. Evaluation of a brief telephone questionnaire to estimate fruit and vegetable consumption in diverse study populations. Epidemiology 1993, 4: 455-463 (Pubitemid 23261379)